Literature DB >> 27212079

Development of a Zika vaccine.

Ralph A Tripp1, Ted M Ross2.   

Abstract

Keywords:  Zika; countermeasures; immunity; vaccine; virus

Mesh:

Substances:

Year:  2016        PMID: 27212079     DOI: 10.1080/14760584.2016.1192474

Source DB:  PubMed          Journal:  Expert Rev Vaccines        ISSN: 1476-0584            Impact factor:   5.217


× No keyword cloud information.
  15 in total

1.  Quantitative Proteomic Analysis of Mosquito C6/36 Cells Reveals Host Proteins Involved in Zika Virus Infection.

Authors:  Qi-Lin Xin; Cheng-Lin Deng; Xi Chen; Jun Wang; Shao-Bo Wang; Wei Wang; Fei Deng; Bo Zhang; Gengfu Xiao; Lei-Ke Zhang
Journal:  J Virol       Date:  2017-05-26       Impact factor: 5.103

2.  Perspectives on the Zika outbreak: herd immunity, antibody-dependent enhancement and vaccine.

Authors:  José Valter Joaquim Silva; Thaísa Regina Rocha Lopes; Edmilson Ferreira de Oliveira-Filho; Renato Antonio Dos Santos Oliveira; Laura Helena Vega Gonzales Gil
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2017-04-13       Impact factor: 1.846

Review 3.  Potential for treatment and a Zika virus vaccine.

Authors:  Natalie Quanquin; Lulan Wang; Genhong Cheng
Journal:  Curr Opin Pediatr       Date:  2017-02       Impact factor: 2.856

Review 4.  Moving beyond Titers.

Authors:  Benjamin D Brooks; Alexander Beland; Gabriel Aguero; Nicholas Taylor; Francina D Towne
Journal:  Vaccines (Basel)       Date:  2022-04-26

Review 5.  Vaccinations for Neuroinfectious Disease: A Global Health Priority.

Authors:  Emily C Leibovitch; Steven Jacobson
Journal:  Neurotherapeutics       Date:  2016-07       Impact factor: 7.620

6.  Evaluation of larvicidal, adulticidal, and anticholinesterase activities of essential oils of Illicium verum Hook. f., Pimenta dioica (L.) Merr., and Myristica fragrans Houtt. against Zika virus vectors.

Authors:  Diego Gomes da Rocha Voris; Luciana Dos Santos Dias; Josélia Alencar Lima; Keila Dos Santos Cople Lima; José Bento Pereira Lima; Antônio Luís Dos Santos Lima
Journal:  Environ Sci Pollut Res Int       Date:  2018-05-28       Impact factor: 5.190

7.  Zika vaccine candidates progress through nonclinical development and enter clinical trials.

Authors:  Alan D T Barrett
Journal:  NPJ Vaccines       Date:  2016-11-10       Impact factor: 7.344

8.  Pushing Forward With Zika Vaccines.

Authors:  Richard B Kennedy
Journal:  EBioMedicine       Date:  2016-10-13       Impact factor: 8.143

9.  Unintended consequences and the paradox of control: Management of emerging pathogens with age-specific virulence.

Authors:  Spencer Carran; Matthew Ferrari; Timothy Reluga
Journal:  PLoS Negl Trop Dis       Date:  2018-04-09

10.  Cost-effectiveness of a potential Zika vaccine candidate: a case study for Colombia.

Authors:  Affan Shoukat; Thomas Vilches; Seyed M Moghadas
Journal:  BMC Med       Date:  2018-07-03       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.